Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

29 August 2022 (08:15 - 09:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mrs Teba Gonzalez Ferrero

La Paz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Ms E. Angeli (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Doctor M. Tokutome (Fukuoka, JP)

Abstract Slides

Presentation thumbnail

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Doctor M. Akao (Kyoto, JP) Doctor M. Iguchi (Kyoto, JP)

Abstract Slides

Presentation thumbnail

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Doctor N. Bonini (Modena, IT)

Abstract Slides

Presentation thumbnail

Survival among people with heart failure and atrial fibrillation; a population cohort study

Doctor N. Jones (Oxford, GB)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure and atrial fibrillation

The Event

Event poster

ESC Congress 2022

29 August 2022 08:15 CET

You may be interested in

Congress Presentation

From hypertension to heart failure: pathophysiology

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Congress Presentation

Fetal recapitulation and cellular stress in the evolution and progression of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources